Literature DB >> 18817841

Estrogen formation in endometrial and cervix cancer cell lines: involvement of aromatase, steroid sulfatase and 17beta-hydroxysteroid dehydrogenases (types 1, 5, 7 and 12).

Michelle-Audrey Fournier1, Donald Poirier.   

Abstract

The involvement of aromatase, steroid sulfatase (STS) and reductive 17beta-hydroxysteroid dehydrogenases (17beta-HSDs) in the production of estrogens was determined in four cell lines of endometrial cancer (Ishikawa, HEC-1A, HEC-1B and RL-95) and one cell line of cervix cancer (Hela) in culture. After incubation with 4-androstene-3,17-dione (4-dione), there are no estrogens, estrone (E1) and estradiol (E2), detected suggesting that the pathway of aromatase is not important in these cell lines. In whole cells, the results show low percentages of transformation of estrone sulfate (E1S) into E1 suggesting that the entrance of E1S is difficult. However, in homogenized cells the STS activity was much higher and fully blocked by an inhibitor. Using selective inhibitors for each reductive 17beta-HSD (types 1, 5, 7 and 12), alone or in combination, we did not succeed in completely blocking the conversion of E1 into E2, suggesting that another 17beta-HSD (known or unknown) is involved in the formation of E2 from E1.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18817841     DOI: 10.1016/j.mce.2008.08.027

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  11 in total

Review 1.  Regulation of 17β-hydroxysteroid dehydrogenases in cancer: regulating steroid receptor at pre-receptor stage.

Authors:  Mirja Rotinen; Joaquín Villar; Ignacio Encío
Journal:  J Physiol Biochem       Date:  2012-02-29       Impact factor: 4.158

2.  Apicidin suppresses transcription of 17β-hydroxysteroid dehydrogenase type 1 in endometrial adenocarcinoma cells.

Authors:  Elif Keleş; Margarita Lianeri; Paweł Piotr Jagodziński
Journal:  Mol Biol Rep       Date:  2010-11-18       Impact factor: 2.316

3.  Identification of Hydroxysteroid (17β) dehydrogenase type 12 (HSD17B12) as a CD8+ T-cell-defined human tumor antigen of human carcinomas.

Authors:  Carmen Visus; Diasuke Ito; Rajiv Dhir; Miroslaw J Szczepanski; Yoo Jung Chang; Jean J Latimer; Stephen G Grant; Albert B DeLeo
Journal:  Cancer Immunol Immunother       Date:  2011-03-16       Impact factor: 6.968

Review 4.  The Immune Microenvironment in Human Papilloma Virus-Induced Cervical Lesions-Evidence for Estrogen as an Immunomodulator.

Authors:  Jayshree R S
Journal:  Front Cell Infect Microbiol       Date:  2021-04-30       Impact factor: 5.293

Review 5.  The Important Roles of Steroid Sulfatase and Sulfotransferases in Gynecological Diseases.

Authors:  Tea Lanišnik Rižner
Journal:  Front Pharmacol       Date:  2016-02-18       Impact factor: 5.810

6.  The Significance of the Sulfatase Pathway for Local Estrogen Formation in Endometrial Cancer.

Authors:  Maša Sinreih; Tamara Knific; Maja Anko; Neli Hevir; Katja Vouk; Aleš Jerin; Snježana Frković Grazio; Tea Lanišnik Rižner
Journal:  Front Pharmacol       Date:  2017-06-23       Impact factor: 5.810

Review 7.  The Regulation of Steroid Action by Sulfation and Desulfation.

Authors:  Jonathan W Mueller; Lorna C Gilligan; Jan Idkowiak; Wiebke Arlt; Paul A Foster
Journal:  Endocr Rev       Date:  2015-07-27       Impact factor: 19.871

8.  Induction of Integrin Signaling by Steroid Sulfatase in Human Cervical Cancer Cells.

Authors:  Dong-Jin Ye; Yeo-Jung Kwon; Sangyun Shin; Hyoung-Seok Baek; Dong-Won Shin; Young-Jin Chun
Journal:  Biomol Ther (Seoul)       Date:  2017-05-01       Impact factor: 4.634

Review 9.  The Importance of Steroid Uptake and Intracrine Action in Endometrial and Ovarian Cancers.

Authors:  Tea Lanišnik Rižner; Theresia Thalhammer; Csilla Özvegy-Laczka
Journal:  Front Pharmacol       Date:  2017-06-19       Impact factor: 5.810

Review 10.  SULFATION PATHWAYS: A role for steroid sulphatase in intracrine regulation of endometrial decidualisation.

Authors:  Douglas A Gibson; Paul A Foster; Ioannis Simitsidellis; Hilary O D Critchley; Olympia Kelepouri; Frances Collins; Philippa T K Saunders
Journal:  J Mol Endocrinol       Date:  2018-05-02       Impact factor: 5.098

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.